Featured Image for Epygenix Therapeutics
First Canadian Participant Dosed in ARGUS Trial, A Phase 2 Potentially Pivotal Study of EPX-100 Treatment of Dravet Syndrome
June 01, 2022 04:00 ET | Epygenix Therapeutics
PARAMUS, N.J., June 01, 2022 (GLOBE NEWSWIRE) -- Epygenix Therapeutics, a clinical-stage biopharmaceutical company focused on genetically screening, discovering and developing safe, effective and...
Adv_Logo_Stacked_7x2 (1).jpg
Argus Sells Private Placement Life Insurance Business to Advantage Insurance
June 27, 2018 08:00 ET | Advantage Insurance Inc.
HAMILTON, Bermuda, June 27, 2018 (GLOBE NEWSWIRE) -- The Argus Group today announces the sale of its private placement life business, which includes Argus International Life Bermuda Limited and its...
Naresh-Mandava-surgery-bionic-eye_006
UCHealth Eye Center Restores Limited Sight to Blind Patient with Region's First Bionic Eye Surgery
December 10, 2015 09:10 ET | UCHealth
AURORA, Colo., Dec. 10, 2015 (GLOBE NEWSWIRE) -- The UCHealth Eye Center at University of Colorado Hospital has performed the first "bionic eye" procedure in the Rocky Mountain region, restoring...
Judicial Watch Obtains Records Detailing Obama Administration's Warrantless Collection of Citizens' Personal Financial Data
June 27, 2013 14:07 ET | Judicial Watch
WASHINGTON, DC--(Marketwired - Jun 27, 2013) - Judicial Watch announced today that it has obtained records from the Consumer Financial Protection Bureau (CFPB) revealing that the agency has spent...